{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T22:37:58Z","timestamp":1778539078755,"version":"3.51.4"},"reference-count":39,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,17]],"date-time":"2023-01-17T00:00:00Z","timestamp":1673913600000},"content-version":"vor","delay-in-days":838,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Austrian Herzfonds"},{"DOI":"10.13039\/501100010109","name":"Medical University of Graz","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010109","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Austrian Ministry of Science, Research and Economy"},{"DOI":"10.13039\/501100006747","name":"Fondazione Cariverona","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006747","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Nutrition"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1093\/jn\/nxaa202","type":"journal-article","created":{"date-parts":[[2020,6,25]],"date-time":"2020-06-25T11:21:57Z","timestamp":1593084117000},"page":"2707-2715","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["The Positive Association between Plasma Myristic Acid and ApoCIII Concentrations in Cardiovascular Disease Patients Is Supported by the Effects of Myristic Acid in HepG2 Cells"],"prefix":"10.1016","volume":"150","author":[{"given":"Oliviero","family":"Olivieri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Speziali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annalisa","family":"Castagna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrizia","family":"Pattini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Udali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Pizzolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Liesinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juergen","family":"Gindlhuber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamara","family":"Tomin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Schittmayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth","family":"Birner-Gruenberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Cecconi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domenico","family":"Girelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simonetta","family":"Friso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Martinelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1093\/jn\/nxaa202_bib1","first-page":"1","article-title":"Changes in the leading cause of death:recent patterns in heart disease and cancer mortality.","volume":"254","author":"Heron","year":"2016","journal-title":"NCHS Data Brief"},{"key":"10.1093\/jn\/nxaa202_bib2","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.atherosclerosis.2019.03.004","article-title":"Triglycerides and cardiovascular risk: apolipoprotein B holds the key.","volume":"284","author":"Stock","year":"2019","journal-title":"Atherosclerosis"},{"issue":"12","key":"10.1093\/jn\/nxaa202_bib3","doi-asserted-by":"crossref","first-page":"e007402","DOI":"10.1161\/JAHA.117.007402","article-title":"Residual risk of atherosclerotic cardiovascular events in relation to reductions in very-low-density lipoproteins.","volume":"6","author":"Lawler","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1093\/jn\/nxaa202_bib4","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.cca.2016.06.016","article-title":"Apoprotein C-III: a review of its clinical implications.","volume":"460","author":"Jin","year":"2016","journal-title":"Clin Chim Acta"},{"key":"10.1093\/jn\/nxaa202_bib5","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.jacl.2015.05.002","article-title":"The risk of cardiovascular events with increased apolipoprotein CIII: a systematic review and meta-analysis.","volume":"9","author":"Wyler von Ballmoos","year":"2015","journal-title":"J Clin Lipidol"},{"key":"10.1093\/jn\/nxaa202_bib6","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa1307095","article-title":"Loss-of-function mutations in APOC3, triglycerides, and coronary disease.","volume":"371","author":"Crosby","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1093\/jn\/nxaa202_bib7","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/MED.0000000000000136","article-title":"Apolipoprotein C-III: a potent modulator of hypertriglyceridemia and cardiovascular disease.","volume":"22","author":"Kohan","year":"2015","journal-title":"Curr Opin Endocrinol"},{"key":"10.1093\/jn\/nxaa202_bib8","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1161\/CIRCULATIONAHA.106.622514","article-title":"Apolipoprotein CIII induces expression of vascular cell adhesion molecule-1 in vascular endothelial cells and increases adhesion of monocytic cells.","volume":"114","author":"Kawakami","year":"2006","journal-title":"Circulation"},{"key":"10.1093\/jn\/nxaa202_bib9","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1161\/CIRCULATIONAHA.108.784785","article-title":"Apolipoprotein CIII links hyperlipidemia with vascular endothelial cell dysfunction.","volume":"118","author":"Kawakami","year":"2008","journal-title":"Circulation"},{"key":"10.1093\/jn\/nxaa202_bib10","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1161\/01.CIR.102.16.1886","article-title":"VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trial.","volume":"102","author":"Sacks","year":"2000","journal-title":"Circulation"},{"key":"10.1093\/jn\/nxaa202_bib11","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1538-7836.2009.03720.x","article-title":"Apolipoprotein C-III predicts cardiovascular mortality in severe coronary artery disease and is associated with an enhanced plasma thrombin generation.","volume":"8","author":"Olivieri","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1093\/jn\/nxaa202_bib12","doi-asserted-by":"crossref","first-page":"e000440","DOI":"10.1161\/JAHA.113.000440","article-title":"Factor II activity is similarly increased in patients with elevated apolipoprotein CIII and in carriers of the factor II 20210A allele.","volume":"2","author":"Olivieri","year":"2013","journal-title":"J Am Heart Assoc"},{"key":"10.1093\/jn\/nxaa202_bib13","doi-asserted-by":"crossref","first-page":"e010973","DOI":"10.1161\/JAHA.118.010973","article-title":"Not just arterial damage: increased incidence of venous thromboembolic events in cardiovascular patients with elevated plasma levels of apolipoprotein CIII.","volume":"8","author":"Olivieri","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1093\/jn\/nxaa202_bib14","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1194\/jlr.M200006-JLR200","article-title":"Biological and genetic determinants of serum apo C-III concentration:reference limits from the Stanislas cohort.","volume":"44","author":"Tilly","year":"2003","journal-title":"J Lipid Res"},{"key":"10.1093\/jn\/nxaa202_bib15","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S0022-2275(20)42003-6","article-title":"Role of the peroxisome proliferatoractivated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression.","volume":"37","author":"Schoonjans","year":"1996","journal-title":"J Lipid Res"},{"key":"10.1093\/jn\/nxaa202_bib16","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1080\/07853890.2018.1511919","article-title":"Effect of omega-3 supplements on plasma apolipoprotein C-III concentrations: a systematic review and meta-analysis of randomized controlled trials.","volume":"50","author":"Sahebkar","year":"2018","journal-title":"Ann Med"},{"key":"10.1093\/jn\/nxaa202_bib17","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.plipres.2008.03.003","article-title":"Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake.","volume":"47","author":"Hodson","year":"2008","journal-title":"Prog Lipid Res"},{"key":"10.1093\/jn\/nxaa202_bib18","doi-asserted-by":"crossref","first-page":"e12045","DOI":"10.1371\/journal.pone.0012045","article-title":"High-throughput analysis of total plasma fatty acid composition with direct in situ transesterification.","volume":"5","author":"Glaser","year":"2010","journal-title":"PLoS One"},{"key":"10.1093\/jn\/nxaa202_bib19","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.3390\/nu11092081","article-title":"Comparison of the utility of total plasma fatty acids versus those in cholesteryl ester, phospholipid, and triglyceride as biomarkers of fatty acid intake.","volume":"11","author":"Furtado","year":"2015","journal-title":"Nutrients"},{"key":"10.1093\/jn\/nxaa202_bib20","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1194\/jlr.M200145-JLR200","article-title":"ApoC-III gene polymorphisms and risk of coronary artery disease.","volume":"43","author":"Olivieri","year":"2002","journal-title":"J Lipid Res"},{"key":"10.1093\/jn\/nxaa202_bib21","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1093\/ajcn\/88.4.941","article-title":"FADS genotypes and desaturase activity estimated by the ratio of arachidonic acid to linoleic acid are associated with inflammation and coronary artery disease.","volume":"88","author":"Martinelli","year":"2008","journal-title":"Am J Clin Nutr"},{"key":"10.1093\/jn\/nxaa202_bib22","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1038\/nbt.2377","article-title":"A cross-platform toolkit for mass spectrometry and proteomics.","volume":"30","author":"Chambers","year":"2012","journal-title":"Nat Biotechnol"},{"key":"10.1093\/jn\/nxaa202_bib23","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1093\/bioinformatics\/btq054","article-title":"Skyline: an open source document editor for creating and analyzing targeted proteomics experiments.","volume":"26","author":"MacLean","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1093\/jn\/nxaa202_bib24","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1194\/jlr.D008888","article-title":"Huh-7 or HepG2 cells:which is the better model for studying human apolipoprotein-B100 assembly and secretion?","volume":"52","author":"Meex","year":"2011","journal-title":"J Lipid Res"},{"key":"10.1093\/jn\/nxaa202_bib25","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1161\/01.ATV.14.4.567","article-title":"Impact of myristic acid versus palmitic acid on serum lipid and lipoprotein levels in healthy women and men.","volume":"14","author":"Zock","year":"1994","journal-title":"Arterioscler Thromb"},{"key":"10.1093\/jn\/nxaa202_bib26","doi-asserted-by":"crossref","first-page":"4416","DOI":"10.3390\/nu7064416","article-title":"Effect of dietary fatty acids on human lipoprotein metabolism: a comprehensive update.","volume":"7","author":"Ooi","year":"2015","journal-title":"Nutrients"},{"key":"10.1093\/jn\/nxaa202_bib27","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/CIR.0000000000000510","article-title":"Dietary fats and cardiovascular disease: a presidential advisory from the American Heart Association.","volume":"136","author":"Sacks","year":"2017","journal-title":"Circulation"},{"key":"10.1093\/jn\/nxaa202_bib28","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1079\/PHN2002391","article-title":"Biomarkers and the measurement of fatty acids.","volume":"5","author":"Arab","year":"2002","journal-title":"Public Health Nutr"},{"key":"10.1093\/jn\/nxaa202_bib29","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0022-2275(20)38686-7","article-title":"Secretion of lipids, apolipoproteins, and lipoproteins by human hepatoma cell line, HepG2: effects of oleic acid and insulin.","volume":"28","author":"Dashti","year":"1987","journal-title":"J Lipid Res"},{"key":"10.1093\/jn\/nxaa202_bib30","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.jacl.2016.09.005","article-title":"The effect of omega-3 carboxylic acids on apolipoprotein CIII\u2013containing lipoproteins in severe hypertriglyceridemia.","volume":"10","author":"Morton","year":"2016","journal-title":"J Clin Lipidol"},{"key":"10.1093\/jn\/nxaa202_bib31","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.atherosclerosis.2015.12.036","article-title":"Myristic acid is associated to low plasma HDL cholesterol levels in a Mediterranean population and increases HDL catabolism by enhancing HDL particles trapping to cell surface proteoglycans in a liver hepatoma cell model.","volume":"246","author":"Noto","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1093\/jn\/nxaa202_bib32","doi-asserted-by":"crossref","first-page":"e000092","DOI":"10.1161\/JAHA.113.000092","article-title":"Biomarkers of dairy fatty acids and risk of cardiovascular disease in the Multi-ethnic Study of Atherosclerosis.","volume":"2","author":"de Oliveira Otto","year":"2012","journal-title":"J Am Heart Assoc"},{"key":"10.1093\/jn\/nxaa202_bib33","doi-asserted-by":"crossref","first-page":"28055","DOI":"10.3402\/ijch.v74.28055","article-title":"Fatty acids linked to cardiovascular mortality are associated with risk factors.","volume":"74","author":"Ebbesson","year":"2015","journal-title":"Int J Circumpolar Health"},{"key":"10.1093\/jn\/nxaa202_bib34","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1017\/S1751731107000122","article-title":"In rat hepatocytes, myristic acid occurs through lipogenesis, palmitic shortening and lauric acid elongation.","volume":"1","author":"Rioux","year":"2007","journal-title":"Animal"},{"key":"10.1093\/jn\/nxaa202_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbalip.2010.09.005","article-title":"Regulation of mammalian desaturases by myristic acid: N-terminal myristoylation and other modulations.","volume":"1811","author":"Rioux","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"10.1093\/jn\/nxaa202_bib36","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1002\/mnfr.201400314","article-title":"GFatty acid chain length and saturation influences PPAR\u00e1 transcriptional activation and repression in HepG2 cells.","volume":"58","author":"Popeijus","year":"2014","journal-title":"Mol Nutr Food Res"},{"key":"10.1093\/jn\/nxaa202_bib37","doi-asserted-by":"crossref","first-page":"13470","DOI":"10.1074\/jbc.270.22.13470","article-title":"Mode of action of peroxisome proliferators as hypolipidemic drugs. Suppression of apolipoprotein CIII.","volume":"270","author":"Hertz","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1093\/jn\/nxaa202_bib38","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s11010-010-0609-0","article-title":"Effect of dietary saturated fatty acids on HNF-4\u03b1 DNA binding activity and ApoCIII mRNA in sedentary rat liver.","volume":"347","author":"Ceccarelli","year":"2011","journal-title":"Mol Cell Biochem"},{"key":"10.1093\/jn\/nxaa202_bib39","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1351\/pac200173040685","article-title":"Lexicon of lipid nutrition (IUPAC Technical Report).","volume":"73","author":"Beare-Rogers","year":"2001","journal-title":"Pure Appl Chem"}],"container-title":["The Journal of Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022316622023288?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022316622023288?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/jn\/article-pdf\/150\/10\/2707\/33864075\/nxaa202.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jn\/article-pdf\/150\/10\/2707\/33864075\/nxaa202.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T22:22:26Z","timestamp":1686694946000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022316622023288"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":39,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S0022316622023288"],"URL":"https:\/\/doi.org\/10.1093\/jn\/nxaa202","relation":{},"ISSN":["0022-3166"],"issn-type":[{"value":"0022-3166","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Positive Association between Plasma Myristic Acid and ApoCIII Concentrations in Cardiovascular Disease Patients Is Supported by the Effects of Myristic Acid in HepG2 Cells","name":"articletitle","label":"Article Title"},{"value":"The Journal of Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1093\/jn\/nxaa202","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 American Society for Nutrition. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}